Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI118896

Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes.

E Bianchi, E Ferrero, F Fazioli, F Mangili, J Wang, J R Bender, F Blasi, and R Pardi

Human Immunology Unit, Scientific Institute San Raffaele-DIBIT, Milano, Italy.

Find articles by Bianchi, E. in: PubMed | Google Scholar

Human Immunology Unit, Scientific Institute San Raffaele-DIBIT, Milano, Italy.

Find articles by Ferrero, E. in: PubMed | Google Scholar

Human Immunology Unit, Scientific Institute San Raffaele-DIBIT, Milano, Italy.

Find articles by Fazioli, F. in: PubMed | Google Scholar

Human Immunology Unit, Scientific Institute San Raffaele-DIBIT, Milano, Italy.

Find articles by Mangili, F. in: PubMed | Google Scholar

Human Immunology Unit, Scientific Institute San Raffaele-DIBIT, Milano, Italy.

Find articles by Wang, J. in: PubMed | Google Scholar

Human Immunology Unit, Scientific Institute San Raffaele-DIBIT, Milano, Italy.

Find articles by Bender, J. in: PubMed | Google Scholar

Human Immunology Unit, Scientific Institute San Raffaele-DIBIT, Milano, Italy.

Find articles by Blasi, F. in: PubMed | Google Scholar

Human Immunology Unit, Scientific Institute San Raffaele-DIBIT, Milano, Italy.

Find articles by Pardi, R. in: PubMed | Google Scholar

Published September 1, 1996 - More info

Published in Volume 98, Issue 5 on September 1, 1996
J Clin Invest. 1996;98(5):1133–1141. https://doi.org/10.1172/JCI118896.
© 1996 The American Society for Clinical Investigation
Published September 1, 1996 - Version history
View PDF
Abstract

In order to reach the sites of inflammation, lymphocytes leave the bloodstream and migrate into peripheral tissues, in a process involving integrin-mediated adhesion to the vascular endothelium, followed by transmigration across the endothelial barrier and through the underlying interstitial matrix. We have investigated the role of the plasminogen activator/plasmin system in normal T cell migration. Receptors for urokinase plasminogen activator (uPAR) were not expressed in resting T lymphocytes, but could be efficiently induced at the mRNA and protein level by coclustering of the antigen receptor complex and beta1 or beta2 integrins, through a signalling pathway involving both protein kinase C activation and an increase in intracellular cyclic AMP. Catalytic activation of plasminogen by uPAR-expressing T cells promoted their migration through an extracellular matrix in vitro. Plasmin-induced invasion was inhibited by plasmin-and urokinase inhibitors and by anti-uPAR antibodies. Finally, cytofluorimetric and immunohistochemical analysis of primary human tumor specimens showed the presence of uPAR positive infiltrating T cells in vivo. Collectively, these findings suggest that plasminogen activation may play a role in lymphocyte migration in vivo, and that integrin-dependent expression of membrane-associated endopeptidases could represent an additional step in the regulated process of leukocyte transmigration.

Version history
  • Version 1 (September 1, 1996): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts